Kenichiro Suwa

Dr. Kenichiro Suwa

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAtsushi Sakamoto
Atsushi Sakamoto
KSKenichiro Suwa
Kenichiro Suwa
RKRika Kawakami
Rika Kawakami
AFAlexandra V. Finn
Alexandra V. Finn
YMYuichiro Maekawa
Yuichiro Maekawa
AFAloke V. Finn
Aloke V. Finn
Acute coronary syndromes due to atherosclerotic coronary artery disease are a leading cause of morbidity and mortality worldwide. Intra-plaque hemorrhage (IPH), caused by disruption of intra-plaque leaky microvessels, is one of the major contributors of plaque progression, causing a sudden increase in plaque volume and eventually plaque destabilization. IPH and its healing processes are highly complex biological events that involve interactions between multiple types of cells in the plaque, including erythrocyte, macrophages, vascular endothelial cells and vascular smooth muscle cells. Recent investigations have unveiled detailed molecular mechanisms by which IPH leads the development of high-risk “vulnerable” plaque. Current advances in clinical diagnostic imaging modalities, such as magnetic resonance image and intra-coronary optical coherence tomography, increasingly allow us to identify IPH in vivo. To date, retrospective and prospective clinical trials have revealed the significance of IPH as detected by various imaging modalities as a reliable prognostic indicator of high-risk plaque. In this review article, we discuss recent advances in our understanding for the significance of IPH on the development of high-risk plaque from basic to clinical points of view.

12 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TITakenori Ikoma
Takenori Ikoma
YNYoshihisa Naruse
Yoshihisa Naruse
YKYutaro Kaneko
Yutaro Kaneko
TSTomoaki Sakakibara
Tomoaki Sakakibara
TNTaro Narumi
Taro Narumi
YMYuichiro Maekawa
Yuichiro Maekawa
Pulmonary vein isolation has become a cornerstone treatment for catheter ablation of atrial fibrillation (AF). Recent reports show that additional ablation targeting low-voltage zones reduces AF recurrence. However, the pre-procedural predictors of low-voltage zones remain elusive. We retrospectively enrolled 359 patients (mean age 63.7 ± 10.8 years; 73 females; and 149 had persistent atrial fibrillation) who underwent catheter ablation for AF and left atrial (LA) voltage mapping during sinus rhythm or atrial pacing. Low-voltage zones were defined as area of > 5 cm2 with a bipolar electrogram amplitude of < 0.50 mV. Overall, 51 (14.2%) patients had low-voltage zones. Patients with low-voltage zones were older (67.9 ± 9.9 vs. 63.0 ± 10.8 years; P = 0.003), predominantly female (33.3% vs. 18.2%; P = 0.013), had higher prevalence of dilated cardiomyopathy (DCM) (11.8% vs. 1.6%; P = 0.002) and hypertrophic cardiomyopathy (HCM) (9.8% vs. 2.6%; P = 0.025), and had larger LA volumes (153.6 ± 46.4 vs. 117.7 ± 67.8 mL; P < 0.001) than those without low-voltage zones. Multivariate logistic regression analysis revealed that age (OR 1.060; 95% CI 1.022–1.101, P = 0.002), female sex (OR 2.978; 95% CI 1.340–6.615, P = 0.007), DCM (OR 8.341; 95% CI 1.381–50.372, P = 0.021), HCM (OR 5.044; 95% CI 1.314–19.363, P = 0.018), persistent AF (OR 4.188; 95% CI 1.928–9.100, P < 0.001), and larger LA volume (OR 3.215; 95% CI 1.378–7.502, P = 0.007) were independently associated with the presence of low-voltage zones. Patient age, female sex, DCM, HCM, persistent AF and larger LA volume may predict the presence of low-voltage zones and could be useful in selecting the appropriate ablation strategy for AF.

6 June 2019 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
KSKenichiro Suwa
Kenichiro Suwa
OROzair Abdul Rahman
Ozair Abdul Rahman
EBEmilie Bollache
Emilie Bollache
MRMichael J. Rose
Michael J. Rose
ARAmir Ali Rahsepar
Amir Ali Rahsepar
MMMichael Markl
Michael Markl

1 September 2019 in Radiology
Verified
Journal Article
Closed access
OROzair Rahman
Ozair Rahman
MMMichael Markl
Michael Markl
PBPallavi Balte
Pallavi Balte
HBHaben Berhane
Haben Berhane
CBCarmen Blanken
Carmen Blanken
RBR. Graham Barr
R. Graham Barr
Right-heart MRI with four-dimensional flow assessment helped to demonstrate that chronic obstructive pulmonary disease was not strongly associated with changes in venous flow to the right heart, bu... BackgroundChronic obstructive pulmonary disease (COPD) is associated with hemodynamic changes in the pulmonary vasculature. However, cardiac effects are not fully understood and vary by phenotype o...

6 December 2023 in Open Heart
Verified
Journal Article
Open access
PDF file
STSanshiro Togo
Sanshiro Togo
YSYuki Sugiura
Yuki Sugiura
SSSayumi Suzuki
Sayumi Suzuki
KOKazuto Ohno
Kazuto Ohno
KAKeitaro Akita
Keitaro Akita
YMYuichiro Maekawa
Yuichiro Maekawa
Objectives In hypertrophic cardiomyopathy (HCM), specific ECG abnormalities are observed. Therefore, ECG is a valuable screening tool. Although several studies have reported on estimating the risk of developing fatal arrhythmias from ECG findings, the use of ECG to identify the severity of heart failure (HF) by applying deep learning (DL) methods has not been established. Methods We assessed whether data-driven machine-learning methods could effectively identify the severity of HF in patients with HCM. A residual neural network-based model was developed using 12-lead ECG data from 218 patients with HCM and 245 patients with non-HCM, categorised them into two (mild-to-moderate and severe) or three (mild, moderate and severe) severities of HF. These severities were defined according to the New York Heart Association functional class and levels of the N-terminal prohormone of brain natriuretic peptide. In addition, the patients were divided into groups according to Kansas City Cardiomyopathy Questionnaire (KCCQ)-12. A transfer learning method was applied to resolve the issue of the low number of target samples. The model was trained in advance using PTB-XL, which is an open ECG dataset. Results The model trained with our dataset achieved a weighted average F1 score of 0.745 and precision of 0.750 for the mild-to-moderate class samples. Similar results were obtained for grouping based on KCCQ-12. Through data analyses using the Guided Gradient Weighted-Class Activation Map and Integrated Gradients, QRS waves were intensively highlighted among true-positive mild-to-moderate class cases, while the highlighted part was highly variable among true-positive severe class cases. Conclusions We developed a model for classifying HF severity in patients with HCM using a deep neural network algorithm with 12-lead ECG data. Our findings suggest that applications of this DL algorithm for using 12-lead ECG data may be useful to classify the HF status in patients with HCM.

19 November 2020 in European Radiology
Verified
Journal Article
Closed access
PDF file
TITakenori Ikoma
Takenori Ikoma
KSKenichiro Suwa
Kenichiro Suwa
MSMakoto Sano
Makoto Sano
TUTakasuke Ushio
Takasuke Ushio
MSMasao Saotome
Masao Saotome
YMYuichiro Maekawa
Yuichiro Maekawa